How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms.

Guy A, Morange PE, James C.

DOI: 10.1182/blood.2024025627
Published: 2025-04-01
Container: Blood
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/blood.2024025627,
  title = {How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms.},
  author = {Guy A and  Morange PE and  James C.},
  year = {2025},
  journal = {Blood},
  doi = {10.1182/blood.2024025627},
  url = {https://doi.org/10.1182/blood.2024025627}
}

RIS

TY  - JOUR
TI  - How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms.
AU  - Guy A
AU  -  Morange PE
AU  -  James C.
PY  - 2025
JO  - Blood
DO  - 10.1182/blood.2024025627
UR  - https://doi.org/10.1182/blood.2024025627
ER  -

APA

A, G., PE, M., & C., J. (2025). How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms.. Blood. https://doi.org/10.1182/blood.2024025627

Source records

europe-pmc · retrieved 2026-09-25T23:25:59.127Z
hal · retrieved 2026-09-25T23:25:59.165Z